Biotechnology
/
Eastern Norway

Xellia Pharmaceuticals AS
Active pharmaceutical ingredients

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 83.514
    Operating profit: 3.539
    Operating profit before tax: 7.439
    Total assets: 550.384
    Total equity: 520.153
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Knut Danielsen

    Board Members:
    Bente Schmidt Nielsen
    Carl-Åke Carlsson
    Frode Flem
    Håvard Klemsdal

    General Manager:
    Carl-Åke Carlsson


    Bandages, Biotechnology, Hygienic or pharmaceutical articles, Medicinal products, Pharmaceutical articles, Plasters,